SG Americas Securities
VERA icon

SG Americas Securities’s Vera Therapeutics VERA Stock Holding History

SG Americas Securities’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
25,358
+12,707
+100% +$473K ﹤0.01% 1822
2026
Q1 		$509K Sell
12,651
-13,743
-52% -$592K ﹤0.01% 2176
2025
Q4 		$1.34M Sell
26,394
-4,951
-16% -$176K ﹤0.01% 1785
2025
Q3 		$911K Buy
+31,345
New +$725K ﹤0.01% 1547
2025
Q2 		– Sell
-9,517
Closed -$229K – 3636
2025
Q1 		$229K Sell
9,517
-10,753
-53% -$346K ﹤0.01% 2439
2024
Q4 		$857K Buy
20,270
+10,916
+117% +$483K ﹤0.01% 934
2024
Q3 		$413K Buy
9,354
+5,053
+117% +$192K ﹤0.01% 1861
2024
Q2 		$156K Sell
4,301
-7,640
-64% -$303K ﹤0.01% 2298
2024
Q1 		$515K Buy
11,941
+4,232
+55% +$151K ﹤0.01% 1410
2023
Q4 		$119K Buy
+7,709
New +$97.9K ﹤0.01% 2626
2023
Q2 		– Sell
-14,384
Closed -$112K – 3213
2023
Q1 		$112K Buy
+14,384
New +$111K ﹤0.01% 2839

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SG Americas Securities's VERA Position: Q2 2026 in Review

SG Americas Securities increased its Vera Therapeutics (VERA) stake by 100% in Q2 2026, buying an estimated $473K and bringing the position to 25,358 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

SG Americas Securities first reported a position in VERA in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.34M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • SG Americas Securities held 25,358 shares of Vera Therapeutics worth $1.09M as of Q2 2026.
  • SG Americas Securities bought 12,707 Vera Therapeutics shares in Q2 2026, an estimated $473K.
  • Vera Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1822 holding.
  • SG Americas Securities first reported a position in Vera Therapeutics in Q1 2023 and has held it in 11 quarters since.
  • SG Americas Securities's Vera Therapeutics position peaked at $1.34M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.